Genetic variants associated with arsenic susceptibility: Study of purine nucleoside phosphorylase, arsenic (+3) methyltransferase, and glutathione S-transferase omega genes

Environmental Health Perspectives

Volumn 116, Issue 4, 2008, Pages 501-505

  De Chaudhuri, Sujata ^a   Ghosh, Pritha ^a   Sarma, Nilendu ^b   Majumdar, Papiya ^c   Sau, Tanmoy Jyoti ^d   Basu, Santanu ^e   Roychoudhury, Susanta ^a   Ray, Kunal ^a   Giri, Ashok K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b NRS MEDICAL COLLEGE   (India)

^c PEERLESS HOSPITAL   (India)

^d CALCUTTA NATIONAL MEDICAL COLLEGE   (India)

^e Sri Aurobindo Seva Kendra ^*  (India)

Author keywords

Arsenic; As3MT; GSTO1; GSTO2; PNP; Skin lesion; Susceptibility

Indexed keywords

ARSENIC; ARSENIC METHYLTRANSFERASE; DRINKING WATER; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE OMEGA; METHYLTRANSFERASE; PURINE NUCLEOSIDE PHOSPHORYLASE;

ADULT; ARSENIC POISONING; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; EXON; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN DEFECT; WATER CONTAMINATION;

ADULT; ARSENIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; INDIA; MALE; METHYLTRANSFERASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PURINE-NUCLEOSIDE PHOSPHORYLASE; SKIN DISEASES; WATER POLLUTANTS, CHEMICAL;

EID: 45749119512     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.10581     Document Type: Article

References (36)

1. Aust MR, Andrews LG, Barrett MJ, Norby-Slycord CJ, Markert ML. 1992. Molecular analysis of mutations in a patient with purine nucleoside phosphorylase deficiency. Am J Hum Genet 51:763-772.
2. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
3. Basu A, Ghosh P, Das JK, Banerjee A, Ray K, Giri AK. 2004. Micronuclei as biomarkers of carcinogen exposure in populations exposed to arsenic through drinking water in West Bengal, India: a comparative study in three cell types. Cancer Epidemiol Biomarkers Prev 13:820-827.
4. Buchet JP, Lauwerys R, Roels H. 1981. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate or dimethylarsinate in man. Int Arch Occup Environ Health 48:71-79.
5. Chakraborti D, Rahman MM, Paul K, Chowdhury UK, Sengpta MK, Lodh D, et al. 2007 Arsenic calamity in the Indian subcontinent what lessons have been learned? Talanta 58:3-22.
6. Chatterjee A, Das D, Mandal BK, Roy Chowdhury T, Samanta G, Chakraborti D. 1995. Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world. I. Arsenic species in drinking water and urine of the affected people. Analyst 120:643-650.
7. Chowdhury UK, Biswas BK, Chowdhury TR, Samanta G, Mandel BK, Basu GC, et al. 2000. Groundwater arsenic contamination in Bangladesh and West Bengal, India. Environ Health Perspect 108:393-397.
8. Das D, Chatterjee A, Mandal BK, Samanta G, Chanda B, Chakraborti D. 1995. Arsenic in groundwater in six districts of West Bengal, India: the biggest arsenic calamity in the world. II. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people. Analyst 120:917-924.
9. De Chaudhuri S, Mahata J, Das JK, Mukherjee A, Ghosh P, Sau TJ, et al. 2006. Association of specific p53 polymorphisms with keratosis in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat Res 601:102-112.
10. Declaration of Helsinki. 2000. The World Medical Association Ethics Unit. Ferney-Voltaire, France: The World Medical Association. Available: http://www.wma.net/e/policy/b3.htm [accessed 5 March 2008].
11. Drobna Z, Waters SB, Deyesa V, Harmon AW, Thomas DJ, Styblo M. 2005. Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferass. Toxicol Appl Pharmacol 207:147-159.
12. Drobna Z, Xing W, Thomas DJ, Styblo M. 2006. shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells. Chem Res Taxicol 19:894-898.
13. Engstrom KS, Broberg K, Concha G, Nermell B, Warholm M, Vahter M. 2007. Genetic polymorphisms influencing arsenic metabolism: Evidence from Argentina. Environ Health Perspect 115:599-605.
14. Frost FJ, Muller T, Petersen HV, Thomson B, Tollestrup K. 2003. Identifying US populations for the study of health effects related to drinking water arsenic. J Expo Anal Environ Epidemiol 13:231-239.
15. Ghosh P, Banerjee M, De Chaudhuri S, Chowdhury R, Das JK, Mukherjee A, et al. 2007. Comparison of health effects between individuals with and without skin lesions in the population exposed to arsenic through drinking water in West Bengal, India. J Expo Sci Environ Epidemiol 17:215-223.
16. Ghosh P, Basu A, Mahata J, Basu S, Sengupta M, Das JK, et al. 2006. Cytogenetic damage and genetic variants in the individuals susceptible to arsenic-induced cancer through drinking water. Int J Cancer 118:2470-2478.
17. Guha Mazumder DN. 2003. Chronic arsenic toxicity: clinical features, epidemiology, and treatment: experience in West Bengal. J Environ Sci Health A Tax Hazard Subst Environ Eng 38:141-163.
18. Haque R, Mazumder DN, Samanta S, Ghosh N, Kalman D, Smith MM, et al. 2003. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology 14:174-182.
19. Hayakawa T, Kobayashi Y, Cui X, Hirano S. 2005. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferese Cyt19. Arch Toxicol 79:183-191.
20. Hirakawa M, Tanaka T, Hasimoto Y, Kuroda M, Takagi T, Nakamura Y. 2002. JSNP: a database of common gene variations in the Japanese population. Nucleic Acid Res 30:158-162.
21. IARC. 2004. Some Drinking Water Disinfectants and Contaminants, including Arsenic. IARC Monogr Eval Carcinog Risks Hum 84:1-477.
22. Marahatta SB, Punyarit P, Bhudisawasdi V, Paupairoj A, Wongkham S, Petmitr S. 2006. Polymorphism of glutathione S-transferase omega gene and risk of cancer. Cancer Lett 236:276-281.
23. Marnell LL, Garcia-Vargas GG, Chowdhury UK, Zakharyan RA, Walsh B, Avram MD, et al. 2003. Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/hGST01 gene and changes in urinary arsenic profiles. Chem Res Toxicol 16:1507-1513.
24. Maze MM, Yu L, Rodriguez YY, Guild M, Thompson D, Gandolfi AJ, et al. 2005. Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CVT19 polymorphisms in children. Environ Health Perspect 113:775-781.
25. Mukherjee B, Salavaggione OE, Palleymounter LL, Moon I, Eckloff BW, Schaid DJ, et al. 2006. Glutathione S-transferase omega 1 and omega 2 pharmacogenomics. Drug Metab Dispos 34:1237-1246.
26. Naranmandura H, Suzuki N, Suzuki KT. 2006. Trivalent arsenicals are bound to proteins during reductive methylation. Chem Res Toxicol 19:1010-1018.
27. NRC (National Research Council). 1999. Arsenic in the Drinking Water. Washington, DC:National Academy Press.
28. Sambrook J. 1989. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY:Cold Spring Harbor Laboratory Press.
29. Schneider S, Roessli D, Excoffier L. 2000. ARLEQUIN: A Software for Population Genetic Data Analysis, ed. 2.000, Genetics and Biometry Laboratory. Available: http://anthro.unige.ch/arlequin/ [accessed 21 May 2007].
30. Tanaka-Kagawa T, Hanioka N, Yoshida H, Jinno H, Ando M. 2003. Arsenite and arsenate activate extracellular signal-regulated kinases 1/2 by an epidermal growth factor receptor-mediated pathway in normal human keratinocytes. Br J Dermatol 149:1116-1127.
31. Vahter M. 2002. Mechanisms of arsenic biotransformation. Toxicology 181-182:211-217.
32. Whitbread AK, Tetlow N, Eyre HJ, Sutherland GR, Board PG. 2003. Characterization of the human Omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics 13:131-144.
33. WHO. 2004. Chemical Fact Sheets, Arsenic. Guidelines for Drinking-Water Quality, 3rd ed. Vol 1. Geneva:World Health Organization, 306-308.
34. Williams SR, Gekeler V, McIvor RS, Martin DW Jr. 1987. A human purine nucleoside phosphorylase deficiency caused by a single base change. J Biol Chem 262:2332-2338.
35. Wood TC, Salavagionne OE, Mukherjee B, Wang L, Klumpp AF, Thomae BA, et al. 2006. Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies. J Biol Chem 281:7364-7373.
36. Yu L, Kalla K, Guthrie E, Vidrine A, Klimecki WT. 2003. Genetic variation in genes associated with arsenic metabolism: glutothione S-transferase omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans. Environ Health Perspect 111:1421-1427.